David B. Berger
Net Worth
Last updated:
What is David B. Berger net worth?
The estimated net worth of Mr. David B. Berger is at least $15,745,051 as of 27 Nov 2023. He owns shares worth $36,645 as insider, has earned $8,296,606 from insider trading and has received compensation worth at least $7,411,800 in Tandem Diabetes Care, Inc..
What is the salary of David B. Berger?
Mr. David B. Berger salary is $617,650 per year as Executive Vice President, Chief Bus. Operations & Compliance Officer and Corporation Sec. in Tandem Diabetes Care, Inc..
How old is David B. Berger?
Mr. David B. Berger is 55 years old, born in 1970.
What stocks does David B. Berger currently own?
As insider, Mr. David B. Berger owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Tandem Diabetes Care, Inc. (TNDM) | Executive Vice President, Chief Bus. Operations & Compliance Officer and Corporation Sec. | 3,365 | $10.89 | $36,645 |
What does Tandem Diabetes Care, Inc. do?
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
David B. Berger insider trading
Tandem Diabetes Care, Inc.
Mr. David B. Berger has made 43 insider trades between 2013-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 18,000 units of TNDM stock on 15 Sep 2021. As of 27 Nov 2023 he still owns at least 3,365 units of TNDM stock.
Tandem Diabetes Care key executives
Tandem Diabetes Care, Inc. executives and other stock owners filed with the SEC:
- Mr. Brian B. Hansen (57) Executive Vice President & Chief Commercial Officer
- Mr. David B. Berger (55) Executive Vice President, Chief Bus. Operations & Compliance Officer and Corporation Sec.
- Mr. John F. Sheridan (70) Pres, Chief Executive Officer & Director
- Ms. Leigh A. Vosseller (52) Executive Vice President, Chief Financial Officer & Treasurer
- Ms. Susan M. Morrison (46) Executive Vice President & Chief Admin. Officer